Carregant...
Renal Medullary Carcinoma Response to Chemotherapy: a Referral Center Experience in Brazil
Renal medullary carcinoma (RMC) is rare, accounting for less than 1% of all renal neoplasms. Case reports suggest RMC is highly aggressive, poorly responsive to chemotherapy, often metastatic at diagnosis, affects young men with sickle cell trait, and median overall survival (mOS) is less than 12 mo...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
PAGEPress Publications, Pavia, Italy
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3804819/ https://ncbi.nlm.nih.gov/pubmed/24179656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/rt.2013.e44 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|